Does NIVOLUMAB Cause Autoimmune hepatitis? 481 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 481 reports of Autoimmune hepatitis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.6% of all adverse event reports for NIVOLUMAB.
481
Reports of Autoimmune hepatitis with NIVOLUMAB
0.6%
of all NIVOLUMAB reports
117
Deaths
315
Hospitalizations
How Dangerous Is Autoimmune hepatitis From NIVOLUMAB?
Of the 481 reports, 117 (24.3%) resulted in death, 315 (65.5%) required hospitalization, and 90 (18.7%) were considered life-threatening.
Is Autoimmune hepatitis Listed in the Official Label?
Yes, Autoimmune hepatitis is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Autoimmune hepatitis?
ATORVASTATIN (357)
IPILIMUMAB (352)
PEMBROLIZUMAB (315)
ADALIMUMAB (237)
INFLIXIMAB (191)
ATEZOLIZUMAB (146)
METHOTREXATE (146)
NITROFURANTOIN (130)
PREDNISONE (107)
CARBOPLATIN (104)
Which NIVOLUMAB Alternatives Have Lower Autoimmune hepatitis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE